Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific Inc. to Further Expand Global Network of Single-Use Technology Manufacturing Sites

09/08/2021 | 08:00am EDT

Thermo Fisher Scientific Inc. announced plans to establish a manufacturing facility in Nashville dedicated to the production of single-use technologies (SUT) products. This investment is in addition to the previously announced expansion to address unprecedented demand in the bioprocessing market. The facility will be one of the world's SUT manufacturing sites and will more than double the company's SUT manufacturing capacity in support of its biopharma customers. The first phase of construction will be operational by the second quarter of 2022. The Nashville site is part of Thermo Fisher's now more than $650 million capital investment to expand its bioprocessing production capabilities across 11 manufacturing sites in North America, Europe and Asia. Additional capacity will be added in 2021 with the completion of expansion projects in Logan, Utah, Suzhou, China, and a new SUT manufacturing site in Singapore. This additional capacity in the SUT network supports global customers as the company's manufacturing strategy utilizes equivalent processes and procedures to manufacture SUT products of consistent quality, form, fit and function worldwide.


ę S&P Capital IQ 2021
All news about THERMO FISHER SCIENTIFIC
10/22THERMO FISHER SCIENTIFIC INC. : Entry into a Material Definitive Agreement, Other Events, ..
AQ
10/20THERMO FISHER SCIENTIFIC : Citigroup Upgrades Thermo Fisher Scientific to Buy from Neutral..
MT
10/20THERMO FISHER SCIENTIFIC : Thinking about trading options or stock in Abbott Laboratories,..
PR
10/20Health Care Stocks Advance Pre-Bell Wednesday
MT
10/20THERMO FISHER SCIENTIFIC : Prices $5.85 Billion Offering of Senior Notes
MT
10/19THERMO FISHER SCIENTIFIC : Prices Offering of USD-Denominated Senior Notes
PR
10/19Thermo Fisher Scientific Inc. Prices Offering of USD-Denominated Senior Notes
CI
10/19THERMO FISHER SCIENTIFIC : Files Shelf Registration for Dollar-Denominated Senior Notes Of..
MT
10/19THERMO FISHER SCIENTIFIC : Announces Offering of USD-Denominated Senior Notes
PR
10/19THERMO FISHER SCIENTIFIC : FDA Authorizes New Saliva Sample Collection Method for High-Thr..
AQ
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2021 36 098 M - -
Net income 2021 7 158 M - -
Net Debt 2021 18 490 M - -
P/E ratio 2021 33,9x
Yield 2021 0,16%
Capitalization 241 B 241 B -
EV / Sales 2021 7,18x
EV / Sales 2022 6,48x
Nbr of Employees 80 000
Free-Float 89,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 611,96 $
Average target price 646,50 $
Spread / Average Target 5,64%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors